Nasdaq-Listed Companies

Breaking the Stigma with Advancements in Psychedelics


In this episode of Breakthrough Economy, MindMed CEO Robert Barrow chats with Host Jen Rogers about how his company, which was the first psychedelic pharmaceutical company to go public, is working to unlock the full therapeutic potential of psychedelics and other novel therapeutic targets.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now